ArticleOncotarget2015

Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma.

Hang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.